3 Passenger Cars Maker, Pumps and Valves Maker and Hospital Network Stocks With a Strong Future Roadmap: Maruti Suzuki, Kirloskar Brothers and Max Healthcare Institute

Car maker, pump and hospital stocks give investors a way to track businesses that sit close to everyday demand in India. Maruti Suzuki, Kirloskar Brothers and Max Healthcare Institute cover a passenger cars maker, a pumps and valves maker and a hospital network.

This list covers three car maker, pump and hospital stocks with complete current figures: Maruti Suzuki, Kirloskar Brothers and Max Healthcare Institute. Every figure comes from the latest reported financials and the 11 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Car Maker, Pump and Hospital Stocks?

Car maker, pump and hospital stocks are listed companies that build and sell cars across price points, make pumps, valves and fluid handling systems for water, industry and power, and run large multi speciality hospitals. Their earnings depend on vehicle demand, water and industrial projects and patient volumes.

Car Maker, Pump and Hospital Stocks at a Glance

On valuation, Kirloskar Brothers and Max Healthcare Institute trade at a P/E below the industry P/E, while Maruti Suzuki trades above it, which reflects the growth the market already expects. Readers comparing car maker, pump and hospital stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in car maker, pump and hospital stocks can use the coming numbers to test whether growth is holding.

Why Do Car Maker, Pump and Hospital Stocks Have a Strong Roadmap in India?

Car maker, pump and hospital stocks have a strong roadmap in India because rising demand for new cars, heavy spending on water and irrigation and growing need for quality hospital care keep widening the market for these companies.

• Cars. Families upgrade to newer cars.
• Pumps and valves. Water and industry need reliable flow equipment.
• Hospitals. Families seek quality specialist care.

Why Maruti Suzuki Features Among These Car Maker, Pump and Hospital Stocks

Among the car maker, pump and hospital stocks on this list, Maruti Suzuki is India's largest passenger car maker, selling a wide range of hatchbacks, sedans and utility vehicles through a vast sales and service network, and it also exports cars to many countries.

The company has a return on equity of 13.7%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 353,984 crore. The stock trades at a P/E of 24.7, above the industry P/E of 23.4.

Revenue rose from Rs 90,074 crore in FY22 to Rs 187,673 crore in FY26, a compound annual growth rate of 20.1%. Net profit grew from Rs 3,880 crore in FY22 to Rs 14,680 crore in FY26, which works out to a compound annual growth rate of 39.5%. In the June 2026 quarter, revenue grew 34.2% year on year to Rs 54,344 crore.

Roadmap: The company is widening its utility vehicle range, adding hybrid and electric models and growing its exports from new capacity. A trusted brand and wide service reach support demand among first-time and repeat buyers.

What to watch: Follow monthly sales, utility vehicle mix, export volumes and progress on electric models.

Why Kirloskar Brothers Features Among These Car Maker, Pump and Hospital Stocks

Among the passenger vehicle, water pump and care network shares on this list, Kirloskar Brothers is a Pune-based maker of pumps, valves and hydro systems used in irrigation, water supply, power plants, buildings and industry. It has served customers for over a century.

Revenue rose from Rs 3,090 crore in FY22 to Rs 4,615 crore in FY26, a compound annual growth rate of 10.5%. Net profit grew from Rs 81.5 crore in FY22 to Rs 361 crore in FY26, which works out to a compound annual growth rate of 45.1%.

In the June 2026 quarter, revenue grew 12.5% year on year to Rs 1,120 crore. The company has a return on equity of 15.2%, a debt to equity ratio of 0.10 and a market capitalisation of Rs 13,186 crore. The stock trades at a P/E of 35.0, below the industry P/E of 43.0.

Roadmap: The company benefits from public spending on water supply, irrigation and urban infrastructure, and it is growing its project and aftermarket business. A deep service network supports repeat orders.

What to watch: Follow order inflows from water and irrigation projects and the share of aftermarket sales.

Why Max Healthcare Institute Features Among These Car Maker, Pump and Hospital Stocks

Among the three companies on this list, Max Healthcare Institute runs a large network of multi-specialty hospitals concentrated in Delhi NCR, Punjab, Uttarakhand and Maharashtra, with a strong presence in oncology, cardiac sciences, neurosciences and orthopaedics.

In the June 2026 quarter, revenue grew 16.6% year on year to Rs 2,407 crore, while net profit rose 4.9% to Rs 323 crore. Revenue rose from Rs 4,059 crore in FY22 to Rs 8,536 crore in FY26, a compound annual growth rate of 20.4%.

Net profit grew from Rs 605 crore in FY22 to Rs 1,442 crore in FY26, which works out to a compound annual growth rate of 24.3%. The company has a return on equity of 13.4%, a debt to equity ratio of 0.32 and a market capitalisation of Rs 80,717 crore. The stock trades at a P/E of 55.4, below the industry P/E of 59.6.

Roadmap: The roadmap rests on adding beds through brownfield expansion at existing campuses and through new hospitals in cities where the group already has referral strength. Higher bed occupancy and a richer case mix lift revenue per occupied bed, which is the number hospital analysts follow most closely.

What to watch: Track how quickly new beds reach stable occupancy and whether average revenue per occupied bed keeps rising.

Maruti Suzuki vs Kirloskar Brothers vs Max Healthcare Institute on Key Financials

The table below sets the three car maker, pump and hospital stocks side by side on revenue, profit and margin, using reported figures.

Kirloskar Brothers posts the highest return on equity in this group at 15.2%. Maruti Suzuki has the largest FY26 revenue at Rs 187,673 crore, and Max Healthcare Institute shows the fastest revenue growth with a 20.4% compound annual rate. A useful habit with car maker, pump and hospital stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several hatchback maker, fluid machinery and hospital chain stocks instead of one name, which keeps a single result from deciding the outcome.

The June 2026 quarter, the latest reported, gives a fresh read on momentum:

Key Risks to Check Before Investing in Car Maker, Pump and Hospital Stocks

Every theme carries risks that deserve a check before any decision. For these car maker, pump and hospital stocks, the main points are: Long-term passenger vehicle, water pump and care network shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

• Production cycles. Vehicle output can vary with demand.
• Government spending. Public project funding can shift between periods.
• Capacity ramp up. New hospitals take time to fill beds and reach full returns.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter car maker, pump and hospital stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Car Maker, Pump and Hospital Stocks

Car maker, pump and hospital stocks work best when investors track growth, valuation and return on equity side by side. Maruti Suzuki, Kirloskar Brothers and Max Healthcare Institute each have a clear plan to grow. Based on the 11 November 2026 close, Maruti Suzuki trades at Rs 13,185, Kirloskar Brothers at Rs 1,635.9 and Max Healthcare Institute at Rs 928.3. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these car maker, pump and hospital stocks to a watchlist.

Download the Univest iOS App or Univest Android App to track car maker, pump and hospital stocks, set price alerts and get research-backed stock ideas.

What are car maker, pump and hospital stocks?

Ans. Car maker, pump and hospital stocks are listed companies that build and sell cars across price points, make pumps, valves and fluid handling systems for water, industry and power, and run large multi speciality hospitals. Their earnings depend on vehicle demand, water and industrial projects and patient volumes. This list looks at three of them, Maruti Suzuki, Kirloskar Brothers and Max Healthcare Institute, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.

Which car maker, pump and hospital stocks are covered in this list?

Ans. This list covers Maruti Suzuki, Kirloskar Brothers and Max Healthcare Institute. Based on the 11 November 2026 close, Maruti Suzuki traded at Rs 13,185, Kirloskar Brothers at Rs 1,635.9 and Max Healthcare Institute at Rs 928.3. Their return on equity ranges from 13.4% to 15.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.5% to 20.4%.

Why do car maker, pump and hospital stocks have a strong future roadmap in India?

Ans. Car maker, pump and hospital stocks have a strong roadmap in India because rising demand for new cars, heavy spending on water and irrigation and growing need for quality hospital care keep widening the market for these companies. The main drivers are as follows. Cars. Families upgrade to newer cars. Pumps and valves. Water and industry need reliable flow equipment. Hospitals. Families seek quality specialist care. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Maruti Suzuki performed financially?

Ans. Revenue rose from Rs 90,074 crore in FY22 to Rs 187,673 crore in FY26, a compound annual growth rate of 20.1%. Net profit grew from Rs 3,880 crore in FY22 to Rs 14,680 crore in FY26, which works out to a compound annual growth rate of 39.5%. In the June 2026 quarter, revenue grew 34.2% year on year to Rs 54,344 crore. The company has a return on equity of 13.7%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 353,984 crore. The stock trades at a P/E of 24.7, above the industry P/E of 23.4. Looking ahead, the company is widening its utility vehicle range, adding hybrid and electric models and growing its exports from new capacity. A trusted brand and wide service reach support demand among first-time and repeat buyers.

How has Kirloskar Brothers performed financially?

Ans. Revenue rose from Rs 3,090 crore in FY22 to Rs 4,615 crore in FY26, a compound annual growth rate of 10.5%. Net profit grew from Rs 81.5 crore in FY22 to Rs 361 crore in FY26, which works out to a compound annual growth rate of 45.1%. In the June 2026 quarter, revenue grew 12.5% year on year to Rs 1,120 crore. The company has a return on equity of 15.2%, a debt to equity ratio of 0.10 and a market capitalisation of Rs 13,186 crore. The stock trades at a P/E of 35.0, below the industry P/E of 43.0. Looking ahead, the company benefits from public spending on water supply, irrigation and urban infrastructure, and it is growing its project and aftermarket business. A deep service network supports repeat orders.

How has Max Healthcare Institute performed financially?

Ans. Revenue rose from Rs 4,059 crore in FY22 to Rs 8,536 crore in FY26, a compound annual growth rate of 20.4%. Net profit grew from Rs 605 crore in FY22 to Rs 1,442 crore in FY26, which works out to a compound annual growth rate of 24.3%. In the June 2026 quarter, revenue grew 16.6% year on year to Rs 2,407 crore, while net profit rose 4.9% to Rs 323 crore. The company has a return on equity of 13.4%, a debt to equity ratio of 0.32 and a market capitalisation of Rs 80,717 crore. The stock trades at a P/E of 55.4, below the industry P/E of 59.6. Looking ahead, the roadmap rests on adding beds through brownfield expansion at existing campuses and through new hospitals in cities where the group already has referral strength. Higher bed occupancy and a richer case mix lift revenue per occupied bed, which is the number hospital analysts follow most closely.

What risks should investors check before buying car maker, pump and hospital stocks?

Ans. Investors should check a few risks before buying car maker, pump and hospital stocks. Production cycles. Vehicle output can vary with demand. Government spending. Public project funding can shift between periods. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of car maker, pump and hospital stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.